PAA 6.25% 17.0¢ pharmaust limited

Hi Pete, just a few extra bits of info …. Relyvrio, were on...

  1. 1,081 Posts.
    lightbulb Created with Sketch. 92
    Hi Pete, just a few extra bits of info ….

    Relyvrio, were on track for 10,000 patient level in the USA. They reached approx 1/3 of that.

    The annual price was approx us$160,000 per patient.

    Thats us$1.6b revenue annually.

    I think you’re undercooking it a bit, put the risk / chance of success in the discount rate or multiple, not on the cash flows.

    However, great initiative & thx, all indications point to significant value accretion, we’re only arguing over magnitude.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.010(6.25%)
Mkt cap ! $82.65M
Open High Low Value Volume
16.0¢ 17.0¢ 15.5¢ $145.3K 876.8K

Buyers (Bids)

No. Vol. Price($)
1 38307 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 302337 3
View Market Depth
Last trade - 15.51pm 23/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.